The objective was to assess glucose, lactate, glycerol, and pyruvate concentrations in the interstitial fluid of the adipose tissue as well as the glucose relative recovery coefficient in reference to capillary blood (RC) during the first two days of the standard treatment of diabetic ketoacidosis (DKA) in patients with type 1 and type 2 diabetes.
Materials and Methods
The study group consisted of 19 patients (12 with type 1 diabetes and 7 with type 2 diabetes). The metabolic state of the patients was monitored using the microdialysis technique. The analysis of variance was used to investigate whether the type of diabetes and the duration of treatment influenced the assessed parameters.
Results
Concentrations of all the monitored components were stable after the initial 12 h of treatment. Glucose concentration was higher and concentrations of all the other components were lower (p<0.0001) in patients with type 1 diabetes than in patients with type 2 diabetes. Significantly higher RC was observed in patients with type 1 diabetes during the initial 12 h.
Conclusions
The results suggest that the standard treatment of DKA is effective in stabilizing a concentration of the studied metabolic components in the interstitial fluid in patients with type 1 and type 2 diabetes despite differences in the glucose concentration at the beginning of the treatment.
EnglishP., WilliamsG.Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J.2004; 80(943): 253–261.
2.
KitabchiA.E., UmpierrezG.E., MurphyM.B.Management of hyperglycemic crises in patients with diabetes. Diabetes Care.2001; 24(1): 131–153.
3.
KitabchiA.E., UmpierrezG.E., MilesJ.M., FisherJ.N.Hyperglycemic crises in adult patients with diabetes. Diabetes Care.2009; 32(7): 1335–1343.
4.
KitabchiA.E., UmpierrezG.E., FisherJ.N., MurphyM.B., StentzF.B.Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab.2008; 93(5): 1541–1552.
5.
MazerM., ChenE.Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?Ann Emerg Med.2009; 53(2): 259–263.
6.
ChiassonJ.L., Aris-JilwanN., BélangerR.Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ.2003; 168(7): 859–866.
7.
HenriksenO.M., PrahlJ.B., RøderM.E., SvendsenO.L.Treatment of diabetic ketoacidosis in adults in Denmark: a national survey. Diabetes Res Clin Pract.2007; 77(1): 113–119.
8.
LiY., PerisJ., ZhongL., DerendorfH.Microdialysis as a tool in local pharmacodynamics. AAPS J.2006; 8(2): E222–235.
9.
MüllerM.Science, medicine, and the future: Microdialysis. BMJ.2002; 324(7337): 588–591.
10.
UngerstedtU.Microdialysis – principles and applications for studies in animals and man. J Intern Med.1991; 230(4): 365–373.
11.
CiechanowskaA., SabalinskaS., GutowskaM.Modern application of membrane technique in therapeutic and diagnostic medical systems. Biocybern Biomed Eng.2008; 28(2): 21–33.
12.
SchoonenA.J., WientjesK.J.A model for transport of glucose in adipose tissue to a microdialysis probe. Diabetes Technol Ther.2003; 5(4): 589–598.
13.
CiechanowskaA., WojcickiJ.M., Maruniak-ChudekI.Microdialysis as a monitoring system for human diabetes. In: TsaiT-H., ed. Applications of Microdialysis in Pharmaceutical Science.Hoboken, New Jersey: John Wiley & Sons; 2011: 359–402.
14.
Hagström-ToftE., BolinderJ., UngerstedtU., ArnerP.A circadian rhythm in lipid mobilization which is altered in IDDM. Diabetologia.1997; 40(9): 1070–1078.
15.
RajamandN., UngerstedtU., BrismarK.Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus. Diabetes Obes Metab.2005; 7(5): 525–535.
16.
KapitzaCh, HövelmannU., NosekL.Continuous Glucose Monitoring during Exercise in Patients with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion. J Diabetes Sci Technol.2010; 4(1): 123–131.
17.
SzabóZ., AnderssonR.G.G., ArnqvistH.J.Intraoperative muscle and fat metabolism in diabetic patients during coronary artery bypass grafting surgery: a parallel microdialysis and organ balance study. Br J Anaesth.2009; 103(2): 166–172.
18.
StolleL.B., Riegels-NielsenP.The metabolism of the diabetic foot: in vivo investigation with microdialysis. Acta Orthop Scand.2004; 75(1): 106–108.
19.
MaderJ.K., FeichtnerF., BockG.Microdialysis – a versatile technology to perform metabolic monitoring in diabetes and critically ill patients. Diabetes Res Clin Pract.2012; 97(1): 112–118.
20.
CiechanowskaA., LadyzynskiP., WojcickiJ.M.Microdialysis technique as a monitoring system for acute complications of diabetes. Artif Organs.2008; 32(1): 45–51.
21.
WojcickiJ.M., CiechanowskaA., SabalinskaS.Microdialysis technique in monitoring of the patient's metabolic state. Biocybern Biomed Eng.2007; 27(1/2): 53–64.
22.
WientjesK.J., VonkP., Vonk-van KleiY., SchoonenA.J., KossenN.W.Microdialysis of glucose in subcutaneous adipose tissue up to 3 weeks in healthy volunteers. Diabetes Care.1998; 21(9): 1481–1488.
23.
MonsodT P., FlanaganD.E., RifeF.Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?Diabetes Care.2002; 25(5): 889–893.
24.
BolinderJ., UngerstedtU., ArnerP.Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet.1993; 342(8879): 1080–1085.
25.
RosdahlH., HamrinK., UngerstedtU., HenrikssonJ.Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol Endocrinol Metab.1998; 274(5 Pt 1): E936–945.
26.
RajamandN., UngerstedtU., BrismarK.Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus. Diabetes Obes Metab.2005; 7(5): 525–535.
27.
PetriczkoE., Horodnicka-JozwaA., Grabowska-WnukW., SienkoM., SyreniczA., WalczakM.Interstitial measurements of glucose, glycerol and lactate in adolescents with decompensated type 1 diabetes. Neuro Endocrinol Lett.2010; 31(4): 559–567.
28.
QvisthV., Hagström-ToftE., MobergE., SjöbergS., BolinderJ.Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women. Am J Physiol Endocrinol Metab.2007; 292(3): E709–714.
29.
SamuvelD.J., SundararajK P., NareikaA., Lopes-VirellaM.F., HuangY.Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol.2009; 182(4): 2476–2484.
30.
SandqvistM.M., ErikssonJ.W., JanssonP.A.Increased lactate release per fat cell in normoglycemic first-degree relatives of individuals with type 2 diabetes. Diabetes.2001; 50(10): 2344–2348.
31.
RosenthalM.D., GlewR.H.Medical Biochemistry: Human Metabolism in Health and Disease.Hoboken, NJ: John Wiley & Sons; 2009.
32.
LowellB.B., ShulmanG.I.Mitochondrial dysfunction and type 2 diabetes. Science.2005; 307(5708): 384–387.
33.
PattiM.E., CorveraS.The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev.2010; 31(3): 364–395.
34.
SivitzW.Mitochondrial dysfunction in obesity and diabetes. US Endocrinology.2010; 6(1): 20–27.
35.
JitrapakdeeS., WutthisathapornchaiA., WallaceJ.C., MacDonaldM.J.Regulation of insulin secretion: role of mitochondrial signalling. Diabetologia.2010; 53(6): 1019–1032.
CrawfordS.O., HoogeveenR.C., BrancatiF.L.Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol.2010; 39(6): 1647–1655.
38.
NurjhanN., ConsoliA., GerichJ.Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest.1992; 89(1): 169–175.
39.
DeFronzoR.A.Overview of newer agents: where treatment is going. Am J Med.2010; 123(3): S38–48.
40.
GroopL.C., SalorantaC., ShankM., BonadonnaR.C., FerranniniE., DeFronzoR.A.The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab.1991; 72(1): 96–107.
41.
BelfortR., MandarinoL., KashyapS.Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes.2005; 54(6): 1640–1648.
42.
VergèsB.Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. Atherosclerosis.2010; 211(2): 353–360.
43.
Hagström-ToftE., EnokssonS., MobergE., BolinderJ., ArnerP.Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. Am J Physiol.1997; 273(3 Pt 1): E584–592.
44.
AimarettiG., CorneliG., RazzoreP.Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab.1998; 83(5): 1615–1618.
